Biologicals

Japanese encephalitis

Proposed revision: Recommendations for Japanese Encephalitis Vaccine (inactivated) for human use

Expert Committee on Biological Standardization, Geneva, 8-12 October 2007

Japanese Encephalitis vaccine, inactivated

Title: Requirements for Japanese Encephalitis Vaccine (Inactivated) for Human Use; Adopted 1987, TRS No 771, Annex 6

Japanese encephalitis vaccine, live attenuated

Title: Guidelines for the production and control of Japanese encephalitis vaccine (live) for human use, Adopted 2000, TRS 910, Annex 3

Upcoming events

WHO Informal Consultation on Regulatory considerations for evaluation of Ebola Vaccines intended for emergency use, WHO/HQ Geneva, Switzerland, 18-19 March 2015

WHO Informal Consultation on Stability Evaluation of Vaccines for use in a Controlled Temperature Chain, WHO/HQ Geneva, Switzerland, 24–26 March 2015

WHO Informal Consultation on Amendment for Similar Biotherapeutic products of monoclonal antibodies, WHO/HQ Geneva, Switzerland, 27–28 April 2015

WHO Informal Consultation on Regulatory risk assessment for biotherapeutic products, WHO/HQ Geneva, Switzerland, 29–30 April 2015

Contacts

Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971